| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |